![]() The New York Timesis assessing the progress in development of potential drug treatments for covid-19, and ranking them for effectiveness and safety. Race Against the Virus: Hunt for a Vaccine is a Channel 4 documentary which tells the story of the coronavirus pandemic through the eyes of the scientists on the frontline. ![]() Panorama: The Race for a Vaccineis a BBC documentary about the inside story of the development of the Oxford/AstraZeneca vaccine against covid-19. ![]() Why Is Covid Killing People of Colour?is a BBC documentary, which investigates what the high covid-19 death rates in ethnic minority patients reveal about health inequality in the UK. The first episode examines the origins of the covid-19 pandemic. The Jumpis a BBC Radio 4 series exploring how viruses can cross from animals into humans to cause pandemics. Our podcast sees expert journalists from the magazine discuss the biggest science stories to hit the headlines each week – from technology and space, to health and the environment. New Scientist Weeklyfeatures updates and analysis on the latest developments in the covid-19 pandemic. What’s the fairest way to share covid-19 vaccines around the world?Ĭovid-19: The story of a pandemic What to read, watch and listen to about coronavirus Long covid: Do I have it, how long will it last and can we treat it? Where did coronavirus come from? And other covid-19 questions answeredĬovid-19 vaccines: Everything you need to know about the leading shots This comes just one week after the city eased restrictions that had confined about 25 million people to their homes since March.Īs of 11 June, people living in the south-western district of Minhang will be placed under “closed management” until they have all been tested. Shanghai in China will lock down 2.7 million people while it conducts mass coronavirus testing. The country’s health ministry reported today that 7240 new coronavirus infections had occurred in the last 24 hours. India has reported its highest number of daily covid-19 cases since March. “These antibody measurements provide an indication that is likely to translate into clinical effects, but an element of uncertainty in extrapolating the results to clinical effectiveness must, inevitably, remain,” Stephen Evans at the London School of Hygiene & Tropical Medicine said in a statement to the Science Media Centre. Whether these raised antibody levels translate into a reduced risk of hospitalisation or death with covid-19 is unknown. “For the first time, we could really be looking at the potential for just once-yearly boosting, because we can get people to such a high level that they will take longer to decay.” “The data we show today are really important because we get a really strong antibody response against Omicron,” Moderna’s chief medical officer Paul Burton told The Guardian on 8 June. One month after receiving the updated booster, the participants’ neutralising antibody levels against omicron had risen by about eight times. In the clinical trial, the updated vaccine was given to 437 people who had already received two full-dose Moderna vaccines and its booster.
0 Comments
Leave a Reply. |